CAPRICOR THERAPEUTICS, INC. (CAPR) Net margin 2016–2024
CAPRICOR THERAPEUTICS, INC. (CAPR) net profit margin by fiscal year — reported net income divided by reported revenue.
-181.7%FY2024 · since FY2016: -470.3% → -181.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -181.7% | -93.2 pp |
| FY2023 | -88.5% | +1048.8 pp |
| FY2022 | -1137.4% | +7038.5 pp |
| FY2021 | -8175.9% | -3773.9 pp |
| FY2020 | -4401.9% | -3641.6 pp |
| FY2019 | -760.4% | +148.5 pp |
| FY2018 | -908.9% | -1000.1 pp |
| FY2017 | 91.2% | +561.5 pp |
| FY2016 | -470.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice